Thanks Roger....Here it is just in case anyone else is listening.
Don't really know what to think other than we're entering a massive population with a "first"!!
Terry
ALTACHEM PHARMA LTD. - ANNOUNCES COMPLETION OF FORMULATION FOR BUFFERED ASPIRIN PROJECT
EDMONTON, ALBERTA--
Warren Jackson, President and Chief Executive Officer of Altachem
Pharma Ltd. (AAF), is pleased to announce the completion of the
formulation for the Buffered Aspirin project. This is the first
of six joint-venture agreements in place with China.
AAF has formulated a 50-mg Buffered Aspirin tablet by using the
local Chinese components (China's Active and Non-active
ingredients). The product meets both the USP (United States
Pharmacoepia) and Chinese standards. A complete technical File
along with 3 different production batches containing ten thousand
Buffered Aspirin tablets have been transferred to China, where
our partners are currently performing the necessary pre-clinical
(pharmacological and toxicological testings) and clinical studies
for a successful registration of the Product with the Ministry of
Public Health (MOPH).
The manufacturing and distribution/marketing agreement is already
in place with a Chinese pharmaceutical company, which has been in
operation, manufacturing and distributing pharmaceutical tablets,
creams, gels and injectables since 1957.
AAF's royalties from gross sales are scheduled to start in the
fourth quarter of 1999 and paid quarterly for seven years.
Aspirin or Acetyl salicylic acid (ASA) is being frequently
prescribed either alone, or in combination with other agents,
for long term use in the prevention of myocardial infarction
disease. In order to avoid gastric intolerance associated with
the chronic use of the product, a buffered formulation was
developed.
Up to now, only enteric - coated Aspirin tablets are available in
China. The 50 mg Buffered Aspirin tablet, which meets the
standard of the Ministry of Public Health will be the first
introduced to the local Chinese market.
For more information, please visit our WEB site
altachempharma.com or contact Warren Jackson at (780)
448-1400 or e-mail warren@altachempharma.com.
For more information visit our World Wide Web page at
internetstockmarket.com
|
